Studies / Chronic kidney disease
Umbilical cord stem cell vesicles for stage 3–4 chronic kidney disease
Nassar W et al., Biomaterials Research, 2016
Better than control
Better than control: The treated group did better than the comparison group on the main measures.
Level 3 of 5: Treated patients were compared with a control: placebo, another treatment, or the untreated side of the face. Most exosome trials at this level are small and short.
See the full key- Design
- Randomized, placebo-controlled (phase II/III)
- People
- 40 people
- Made from
- Umbilical cord
- How it was given
- Two doses
What they found
The authors reported better kidney function (eGFR) and lower inflammation markers in the treated group than with placebo.
What limits it
A small, single-center trial.